Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Aemetis Inc. is poised for significant growth, as projected revenues are expected to increase from $398 million in 2025 to $1.8 billion by 2036, reflecting an impressive eleven-year compound annual growth rate (CAGR) of approximately 14.4%. The company's ongoing operational execution is bolstered by growth catalysts, including the anticipated rebound of its India business with new contracts and the potential cash flows from its renewable natural gas (RNG) operations, along with the planned IPO of its biodiesel business in 2025 which could enhance its balance sheet. Despite an expected increase in operating expenses at an eleven-year CAGR of 8.9%, the current share price is seen as an attractive opportunity given the company's foundational growth strategies and future profitability potential.

Bears say

Aemetis Inc reported a significant decline in its India operations, with revenues falling to $3 million in Q4 from $32 million in Q3 2024, indicating a substantial drop in performance. The company experienced a net loss of $16.2 million for Q4 2024, although this was a slight improvement compared to the net loss of $25.4 million in the same quarter of the prior year. Additionally, the earnings per share (EPS) of $(0.36) was not only worse than estimated expectations but also revealed ongoing financial challenges within the company's operational framework.

Aemetis (AMTX) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Buy based on their latest research and market trends.

According to 8 analysts, Aemetis (AMTX) has a Buy consensus rating as of Jul 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.